Top Cancer companies by Market Cap
Browse the largest Cancer companies in the world ranked by their Market Capitalization. Global Cancer Companies market cap is $215.06B.
13 Dec 2024, 07:33 UTC
Companies: 253
🇺🇸201 |  | $0.49 | -12.60% | 19.62M | -83.35% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷202 |  | $0.37 | 0.38% | 19.44M | -56.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵203 |  | $0.31 | -6.00% | 19.42M | -45.35% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪204 |  | $0.40 | -3.83% | 18.30M | -66.76% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺205 |  | $0.06 | -2.00% | 18.25M | 32.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷206 |  | $1.08 | 3.00% | 17.95M | -44.62% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸207 |  | $0.25 | -10.71% | 16.10M | -89.22% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸208 |  | $0.84 | -1.30% | 16.07M | -80.80% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷209 |  | $0.84 | 3.72% | 14.82M | -43.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸210 |  | $1.67 | 0.60% | 14.39M | -24.09% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦211 |  | $0.16 | 0.00% | 14.38M | -10.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷212 |  | $3.93 | -1.06% | 14.31M | -35.52% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇺🇸213 |  | $1.32 | -6.38% | 14.12M | -30.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸214 |  | $0.39 | -0.77% | 13.92M | -68.79% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦215 |  | $0.10 | 0.00% | 13.56M | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸216 |  | $3.52 | -2.24% | 13.15M | -25.12% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸217 |  | $0.08 | 0.00% | 12.90M | -37.50% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸218 |  | $0.29 | -9.35% | 12.58M | -78.76% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸219 |  | $0.48 | -3.02% | 11.13M | -80.56% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸220 |  | $0.22 | 4.81% | 10.75M | -49.98% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸221 |  | $0.43 | -1.15% | 10.75M | -39.35% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸222 |  | $2.12 | -0.93% | 10.36M | -26.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦223 |  | $0.66 | -39.89% | 10.33M | -88.79% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷224 |  | $1.40 | 3.34% | 10.24M | -40.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇬225 |  | $0.01 | 0.00% | 9.79M | 53.85% | Outperform S&P500 YTD Benchamark | ⚕️💻 Healthtech | - |
🇮🇱226 |  | $0.01 | 0.00% | 9.63M | -26.92% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸227 |  | $1.59 | -3.05% | 9.44M | -37.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸228 |  | $0.97 | 1.97% | 9.25M | -37.58% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸229 |  | $0.17 | -1.14% | 9.01M | 19.31% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇺🇸230 |  | $0.70 | -2.71% | 8.65M | 52.28% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸231 |  | $1.01 | 3.06% | 8.49M | -43.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧232 |  | $0.02 | 0.00% | 8.30M | -7.69% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸233 |  | $0.85 | 1.19% | 7.99M | 21.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧234 |  | $0.06 | 11.63% | 7.86M | -33.79% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸235 |  | $0.98 | 8.89% | 7.10M | 63.33% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦236 |  | $0.10 | -3.45% | 6.87M | 64.71% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸237 |  | $0.24 | -3.67% | 6.14M | -96.91% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸238 |  | $1.04 | -0.95% | 6.12M | 87.39% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸239 |  | $1.44 | -8.86% | 5.67M | 117.52% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸240 |  | $1.91 | -2.05% | 4.30M | -21.07% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸241 |  | $0.81 | 0.00% | 4.25M | 33.20% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪242 |  | $0.15 | -2.36% | 3.96M | -70.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸243 |  | $1.10 | -0.90% | 3.51M | -21.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸244 |  | $0.26 | -14.84% | 3.24M | -90.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇭245 |  | $0.03 | -40.00% | 1.97M | -28.57% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧246 |  | $0.01 | 0.95% | 1.85M | -66.88% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸247 |  | $1.77 | -7.33% | 1.84M | 1.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦248 |  | $0.19 | 6.94% | 1.53M | -92.39% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸249 |  | $0.00 | -15.63% | 1.38M | -43.75% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇪250 |  | $0.08 | -3.68% | 1.38M | -68.11% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸251 |  | $0.95 | 0.00% | 1.20M | -4.04% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸252 |  | $0.01 | 23.76% | 1.19M | -99.39% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦253 |  | $0.01 | 0.00% | 1.10M | -47.02% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
